▶ 調査レポート

世界の中性ホウケイ酸ガラス注入バイアル市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Neutral Borosilicate Glass Injection Vial Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の中性ホウケイ酸ガラス注入バイアル市場2023年:企業・地域・種類・用途別分析 / Global Neutral Borosilicate Glass Injection Vial Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z7386資料のイメージです。• レポートコード:MRC309Z7386
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の中性ホウケイ酸ガラス注入バイアルの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の中性ホウケイ酸ガラス注入バイアル市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 中性ホウケイ酸ガラス注入バイアルの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

中性ホウケイ酸ガラス注入バイアル市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・制御注入バイアル、成型注入バイアル

用途別セグメント
・医薬品、ワクチン

主要な市場プレーヤー
・SCHOTT、Cangzhou Four Stars Glass、Chongqing Zhengchuan Pharmaceutical Packaging、Shandong Pharmaceutical Glass、Nipro、Chengdu Jingu Pharma-Pack、Gerresheimer Shuangfeng、Linuo、Wuhu Changjiang Glass Products、Anhui Huaxin Pharmaceutical Glass Products、SGD Pharma、Famacy Group、JOTOP GLASS

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、中性ホウケイ酸ガラス注入バイアル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な中性ホウケイ酸ガラス注入バイアルメーカーの企業概要、2019年~2022年までの中性ホウケイ酸ガラス注入バイアルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な中性ホウケイ酸ガラス注入バイアルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別中性ホウケイ酸ガラス注入バイアルの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの中性ホウケイ酸ガラス注入バイアルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での中性ホウケイ酸ガラス注入バイアル市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および中性ホウケイ酸ガラス注入バイアルの産業チェーンを掲載しています。
・第14、15章では、中性ホウケイ酸ガラス注入バイアルの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 中性ホウケイ酸ガラス注入バイアルの概要
- 種類別分析(2018年vs2022年vs2029年):制御注入バイアル、成型注入バイアル
- 用途別分析(2018年vs2022年vs2029年):医薬品、ワクチン
- 世界の中性ホウケイ酸ガラス注入バイアル市場規模・予測
- 世界の中性ホウケイ酸ガラス注入バイアル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- SCHOTT、Cangzhou Four Stars Glass、Chongqing Zhengchuan Pharmaceutical Packaging、Shandong Pharmaceutical Glass、Nipro、Chengdu Jingu Pharma-Pack、Gerresheimer Shuangfeng、Linuo、Wuhu Changjiang Glass Products、Anhui Huaxin Pharmaceutical Glass Products、SGD Pharma、Famacy Group、JOTOP GLASS
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:制御注入バイアル、成型注入バイアル
・用途別分析2018年-2029年:医薬品、ワクチン
・中性ホウケイ酸ガラス注入バイアルの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・中性ホウケイ酸ガラス注入バイアルのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・中性ホウケイ酸ガラス注入バイアルのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・中性ホウケイ酸ガラス注入バイアルの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・中性ホウケイ酸ガラス注入バイアルの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Neutral Borosilicate Glass Injection Vial market size was valued at USD 1498.2 million in 2022 and is forecast to a readjusted size of USD 2816.4 million by 2029 with a CAGR of 9.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
At present, the world’s neutral borosilicate glass is mainly supplied by SCHOTT of Germany, NEG of Nippon Electric Glass, CORNING of the United States and Nipro, which are expensive. International pharmaceutical companies generally choose medium borosilicate glass as the material for injection bottles. Injection bottles made of neutral borosilicate glass have incomparable advantages over injection bottles made of ordinary soda lime glass and low borosilicate glass. With the maturity of the production process of neutral borosilicate glass and the entry of new market players, the market size of injection bottles is expected to continue to grow.
Neutral borosilicate glass: The average linear thermal expansion coefficient of medium borosilicate glass is: α=(4-5)×10-6/°C (20-300°C), referred to as 5.0 glass, invented and started production by Schott in Germany in 1889 ( It was named Fiolax at that time), and its composition was SiO266%, B2O37%, Al2O310%, CaO6%, Na2O8%, K2O3%. According to the modern classification standard of B2O3 content, the original Fiolax can only be counted as low borosilicate glass. In 1943, Kimble in the United States invented medium borosilicate glass with a B2O3 content greater than 8%, and then Germany, Japan and other countries successively produced this medium borosilicate glass. This type of glass is widely used in the field of pharmaceutical packaging due to its good material and performance, especially its excellent chemical stability. Neutral borosilicate glass is far superior to low borosilicate glass in terms of water resistance, acid and alkali resistance, freezing resistance, thermal stability, filling speed, etc. There will be no sedimentation in long-term contact with liquid medicine and blood. Injection vials made of neutral borosilicate glass offer additional advantages.
This report is a detailed and comprehensive analysis for global Neutral Borosilicate Glass Injection Vial market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neutral Borosilicate Glass Injection Vial market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neutral Borosilicate Glass Injection Vial market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neutral Borosilicate Glass Injection Vial market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neutral Borosilicate Glass Injection Vial market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neutral Borosilicate Glass Injection Vial
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neutral Borosilicate Glass Injection Vial market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SCHOTT, Cangzhou Four Stars Glass, Chongqing Zhengchuan Pharmaceutical Packaging, Shandong Pharmaceutical Glass and Nipro, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neutral Borosilicate Glass Injection Vial market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Controlled Injection Vials
Molded Injection Vials
Market segment by Application
Medicine
Vaccine
Major players covered
SCHOTT
Cangzhou Four Stars Glass
Chongqing Zhengchuan Pharmaceutical Packaging
Shandong Pharmaceutical Glass
Nipro
Chengdu Jingu Pharma-Pack
Gerresheimer Shuangfeng
Linuo
Wuhu Changjiang Glass Products
Anhui Huaxin Pharmaceutical Glass Products
SGD Pharma
Famacy Group
JOTOP GLASS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neutral Borosilicate Glass Injection Vial product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neutral Borosilicate Glass Injection Vial, with price, sales, revenue and global market share of Neutral Borosilicate Glass Injection Vial from 2018 to 2023.
Chapter 3, the Neutral Borosilicate Glass Injection Vial competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neutral Borosilicate Glass Injection Vial breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neutral Borosilicate Glass Injection Vial market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neutral Borosilicate Glass Injection Vial.
Chapter 14 and 15, to describe Neutral Borosilicate Glass Injection Vial sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Neutral Borosilicate Glass Injection Vial
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neutral Borosilicate Glass Injection Vial Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Controlled Injection Vials
1.3.3 Molded Injection Vials
1.4 Market Analysis by Application
1.4.1 Overview: Global Neutral Borosilicate Glass Injection Vial Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Medicine
1.4.3 Vaccine
1.5 Global Neutral Borosilicate Glass Injection Vial Market Size & Forecast
1.5.1 Global Neutral Borosilicate Glass Injection Vial Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neutral Borosilicate Glass Injection Vial Sales Quantity (2018-2029)
1.5.3 Global Neutral Borosilicate Glass Injection Vial Average Price (2018-2029)
2 Manufacturers Profiles
2.1 SCHOTT
2.1.1 SCHOTT Details
2.1.2 SCHOTT Major Business
2.1.3 SCHOTT Neutral Borosilicate Glass Injection Vial Product and Services
2.1.4 SCHOTT Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 SCHOTT Recent Developments/Updates
2.2 Cangzhou Four Stars Glass
2.2.1 Cangzhou Four Stars Glass Details
2.2.2 Cangzhou Four Stars Glass Major Business
2.2.3 Cangzhou Four Stars Glass Neutral Borosilicate Glass Injection Vial Product and Services
2.2.4 Cangzhou Four Stars Glass Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cangzhou Four Stars Glass Recent Developments/Updates
2.3 Chongqing Zhengchuan Pharmaceutical Packaging
2.3.1 Chongqing Zhengchuan Pharmaceutical Packaging Details
2.3.2 Chongqing Zhengchuan Pharmaceutical Packaging Major Business
2.3.3 Chongqing Zhengchuan Pharmaceutical Packaging Neutral Borosilicate Glass Injection Vial Product and Services
2.3.4 Chongqing Zhengchuan Pharmaceutical Packaging Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments/Updates
2.4 Shandong Pharmaceutical Glass
2.4.1 Shandong Pharmaceutical Glass Details
2.4.2 Shandong Pharmaceutical Glass Major Business
2.4.3 Shandong Pharmaceutical Glass Neutral Borosilicate Glass Injection Vial Product and Services
2.4.4 Shandong Pharmaceutical Glass Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shandong Pharmaceutical Glass Recent Developments/Updates
2.5 Nipro
2.5.1 Nipro Details
2.5.2 Nipro Major Business
2.5.3 Nipro Neutral Borosilicate Glass Injection Vial Product and Services
2.5.4 Nipro Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nipro Recent Developments/Updates
2.6 Chengdu Jingu Pharma-Pack
2.6.1 Chengdu Jingu Pharma-Pack Details
2.6.2 Chengdu Jingu Pharma-Pack Major Business
2.6.3 Chengdu Jingu Pharma-Pack Neutral Borosilicate Glass Injection Vial Product and Services
2.6.4 Chengdu Jingu Pharma-Pack Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chengdu Jingu Pharma-Pack Recent Developments/Updates
2.7 Gerresheimer Shuangfeng
2.7.1 Gerresheimer Shuangfeng Details
2.7.2 Gerresheimer Shuangfeng Major Business
2.7.3 Gerresheimer Shuangfeng Neutral Borosilicate Glass Injection Vial Product and Services
2.7.4 Gerresheimer Shuangfeng Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Gerresheimer Shuangfeng Recent Developments/Updates
2.8 Linuo
2.8.1 Linuo Details
2.8.2 Linuo Major Business
2.8.3 Linuo Neutral Borosilicate Glass Injection Vial Product and Services
2.8.4 Linuo Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Linuo Recent Developments/Updates
2.9 Wuhu Changjiang Glass Products
2.9.1 Wuhu Changjiang Glass Products Details
2.9.2 Wuhu Changjiang Glass Products Major Business
2.9.3 Wuhu Changjiang Glass Products Neutral Borosilicate Glass Injection Vial Product and Services
2.9.4 Wuhu Changjiang Glass Products Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Wuhu Changjiang Glass Products Recent Developments/Updates
2.10 Anhui Huaxin Pharmaceutical Glass Products
2.10.1 Anhui Huaxin Pharmaceutical Glass Products Details
2.10.2 Anhui Huaxin Pharmaceutical Glass Products Major Business
2.10.3 Anhui Huaxin Pharmaceutical Glass Products Neutral Borosilicate Glass Injection Vial Product and Services
2.10.4 Anhui Huaxin Pharmaceutical Glass Products Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Anhui Huaxin Pharmaceutical Glass Products Recent Developments/Updates
2.11 SGD Pharma
2.11.1 SGD Pharma Details
2.11.2 SGD Pharma Major Business
2.11.3 SGD Pharma Neutral Borosilicate Glass Injection Vial Product and Services
2.11.4 SGD Pharma Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SGD Pharma Recent Developments/Updates
2.12 Famacy Group
2.12.1 Famacy Group Details
2.12.2 Famacy Group Major Business
2.12.3 Famacy Group Neutral Borosilicate Glass Injection Vial Product and Services
2.12.4 Famacy Group Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Famacy Group Recent Developments/Updates
2.13 JOTOP GLASS
2.13.1 JOTOP GLASS Details
2.13.2 JOTOP GLASS Major Business
2.13.3 JOTOP GLASS Neutral Borosilicate Glass Injection Vial Product and Services
2.13.4 JOTOP GLASS Neutral Borosilicate Glass Injection Vial Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 JOTOP GLASS Recent Developments/Updates
3 Competitive Environment: Neutral Borosilicate Glass Injection Vial by Manufacturer
3.1 Global Neutral Borosilicate Glass Injection Vial Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neutral Borosilicate Glass Injection Vial Revenue by Manufacturer (2018-2023)
3.3 Global Neutral Borosilicate Glass Injection Vial Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neutral Borosilicate Glass Injection Vial by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neutral Borosilicate Glass Injection Vial Manufacturer Market Share in 2022
3.4.2 Top 6 Neutral Borosilicate Glass Injection Vial Manufacturer Market Share in 2022
3.5 Neutral Borosilicate Glass Injection Vial Market: Overall Company Footprint Analysis
3.5.1 Neutral Borosilicate Glass Injection Vial Market: Region Footprint
3.5.2 Neutral Borosilicate Glass Injection Vial Market: Company Product Type Footprint
3.5.3 Neutral Borosilicate Glass Injection Vial Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neutral Borosilicate Glass Injection Vial Market Size by Region
4.1.1 Global Neutral Borosilicate Glass Injection Vial Sales Quantity by Region (2018-2029)
4.1.2 Global Neutral Borosilicate Glass Injection Vial Consumption Value by Region (2018-2029)
4.1.3 Global Neutral Borosilicate Glass Injection Vial Average Price by Region (2018-2029)
4.2 North America Neutral Borosilicate Glass Injection Vial Consumption Value (2018-2029)
4.3 Europe Neutral Borosilicate Glass Injection Vial Consumption Value (2018-2029)
4.4 Asia-Pacific Neutral Borosilicate Glass Injection Vial Consumption Value (2018-2029)
4.5 South America Neutral Borosilicate Glass Injection Vial Consumption Value (2018-2029)
4.6 Middle East and Africa Neutral Borosilicate Glass Injection Vial Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
5.2 Global Neutral Borosilicate Glass Injection Vial Consumption Value by Type (2018-2029)
5.3 Global Neutral Borosilicate Glass Injection Vial Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
6.2 Global Neutral Borosilicate Glass Injection Vial Consumption Value by Application (2018-2029)
6.3 Global Neutral Borosilicate Glass Injection Vial Average Price by Application (2018-2029)
7 North America
7.1 North America Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
7.2 North America Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
7.3 North America Neutral Borosilicate Glass Injection Vial Market Size by Country
7.3.1 North America Neutral Borosilicate Glass Injection Vial Sales Quantity by Country (2018-2029)
7.3.2 North America Neutral Borosilicate Glass Injection Vial Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
8.2 Europe Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
8.3 Europe Neutral Borosilicate Glass Injection Vial Market Size by Country
8.3.1 Europe Neutral Borosilicate Glass Injection Vial Sales Quantity by Country (2018-2029)
8.3.2 Europe Neutral Borosilicate Glass Injection Vial Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neutral Borosilicate Glass Injection Vial Market Size by Region
9.3.1 Asia-Pacific Neutral Borosilicate Glass Injection Vial Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neutral Borosilicate Glass Injection Vial Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
10.2 South America Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
10.3 South America Neutral Borosilicate Glass Injection Vial Market Size by Country
10.3.1 South America Neutral Borosilicate Glass Injection Vial Sales Quantity by Country (2018-2029)
10.3.2 South America Neutral Borosilicate Glass Injection Vial Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Neutral Borosilicate Glass Injection Vial Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neutral Borosilicate Glass Injection Vial Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neutral Borosilicate Glass Injection Vial Market Size by Country
11.3.1 Middle East & Africa Neutral Borosilicate Glass Injection Vial Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neutral Borosilicate Glass Injection Vial Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Neutral Borosilicate Glass Injection Vial Market Drivers
12.2 Neutral Borosilicate Glass Injection Vial Market Restraints
12.3 Neutral Borosilicate Glass Injection Vial Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Neutral Borosilicate Glass Injection Vial and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neutral Borosilicate Glass Injection Vial
13.3 Neutral Borosilicate Glass Injection Vial Production Process
13.4 Neutral Borosilicate Glass Injection Vial Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neutral Borosilicate Glass Injection Vial Typical Distributors
14.3 Neutral Borosilicate Glass Injection Vial Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer